Mayo Clinic researchers were among the first to describe primary sclerosing cholangitis. Other research done at Mayo has helped to refine diagnostic tests, improve treatment and assess the results of liver transplants for people with primary sclerosing cholangitis. Mayo Clinic researchers also developed mathematical models to help physicians predict long-term survival for people with primary sclerosing cholangitis.

Researchers at Mayo Clinic are currently studying the use of the fluorescence in situ hybridization (FISH) test in the diagnosis of bile duct cancer in people with primary sclerosing cholangitis. Another study is looking at genetic predisposition to primary sclerosing cholangitis.

Basic research related to primary sclerosing cholangitis and other liver diseases is conducted in the following Mayo Clinic laboratories:

Publications

See a list of publications by Mayo Clinic doctors on primary sclerosing cholangitis on PubMed, a service of the National Library of Medicine.

Research profiles

Aug. 15, 2014

You Are ... The Campaign for Mayo Clinic

Mayo Clinic is a not-for-profit organization. Make a difference today.